The Institute for Therapeutic Discovery Inc

EIN: 200109928 501(c)(3)

Providence, RI

Total Revenue
$43,374
Total Expenses
$46,189
Total Assets
$51,040
Net Assets
$27,531
🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Sign In — Free (10 views/day)

Financial Trends

Organization Details

Formation Year
2003
Legal Domicile
NY
Principal Officer
John McMichael
Phone
5184796700
Tax Period
2020-07-01 to 2021-06-30

The Institute for Therapeutic Discovery Inc, founded in 2003, is a micro nonprofit that reported $43K in total revenue in fiscal year 2020. Revenue fell 47% from the prior year — a significant decline worth monitoring.

Mission

DISCOVERY AND EARLY-STAGE RESEARCH BUILT ON BRIDGING BIOPHYSICS AND BIOCHEMISTRY TO HELP PHYSICIANS TREAT DISEASE BY RESTORING NATURAL FUNCTION AT THE CELLULAR LEVEL

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Sign In — Free (10 views/day)

Financial Overview (2020)

Revenue Breakdown

Contributions & Grants $36,149
Program Service Revenue $0
Investment Income $0
Other Revenue $7,225
TOTAL REVENUE $43,374

Expense Breakdown

Grants Paid $0
Salaries & Benefits $0
Fundraising Expenses $0
Program Expenses $41,465
Other Expenses $46,189
TOTAL EXPENSES $46,189

Year-over-Year Comparison

2020 2019 Change
Revenue $43,374 $81,391 -0.5%
Expenses $46,189 $48,831 -0.1%
Net Income $-2,815 $32,560 -1.1%
Key Indicators
✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required
🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Sign In

Governance

Voting Members
3
Independent Members
3
Employees
N/A
Volunteers
N/A

Governance Policies

✗ Conflict of Interest Policy
✗ Whistleblower Policy
✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School
✗ Operated a Hospital
✗ Provided First Class Travel
✗ Reported Conflict of Interest
✗ Reported Asset Diversion
✗ Excess Benefit Transaction
✗ Made Political Expenditures
✗ Engaged in Lobbying
✗ Operated Donor Advised Fund
✗ Maintained Art Collections
✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers
0
$0
Total Directors
4
$0
Key Employees
0
$0
Highest Compensated
0
reported
Name Title Hours/Week Role Reportable Comp Other Comp Total
Dr Kara Fitzgerald Director 000.10
Director
$0 $0 $0
Dr Lloyd Saberski Director 000.10
Director
$0 $0 $0
Dr Betty Sadaniantz Director 000.10
Director
$0 $0 $0
Dr John McMichael Chief Exec Officer 005.00
Director
$0 $0 $0
Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year Revenue Expenses Assets Net Income
2021 $43,374 $46,189 $51,040 $-2,815
2018 $240,823 $204,450 $1,989 $36,373
Explore More Nonprofits
→Top 100 Nonprofits in Rhode Island →Largest U.S. Nonprofits →Best Rated Nonprofits →Most Efficient Nonprofits

Compare The Institute for Therapeutic Discovery Inc with other nonprofits in Rhode Island and across the country.

We Value Your Privacy
We use cookies and similar technologies to analyze site traffic and improve your experience. By clicking "Accept All", you consent to our use of cookies for analytics and measurement.